Back to GetFilings.com



Table of Contents

 


 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 


 

FORM 10-Q

 

Mark One

 

x   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2003

 

or

 

¨   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO

 


 

Commission File Number: 000-30681

 

 

DENDREON CORPORATION

(Exact name of registrant as specified in its charter)

 


 

DELAWARE

 

22-3203193

(State or other jurisdiction of incorporation or organization)

 

(IRS Employer Identification No.)

 

 

3005 FIRST AVENUE, SEATTLE, WASHINGTON 98121

(Address of principal executive offices, including zip code)

 

 

(206) 256-4545

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    x  Yes    ¨  No

 

The number of shares of the registrant’s common stock, $.001 par value, outstanding as of April 24, 2003 was 26,813,004.

 



Table of Contents

 

DENDREON CORPORATION

 

INDEX

 

                

PAGE NO.


PART I.

  

FINANCIAL INFORMATION

      
    

Item 1.

  

Financial Statements

      
         

a) Condensed Balance Sheets as of March 31, 2003 (unaudited) and December 31, 2002

    

2

         

b) Condensed Statements of Operations for the Three Months Ended March 31, 2003 and 2002 (unaudited)

    

3

         

c) Condensed Statements of Cash Flows for the Three Months Ended March 31, 2003 and 2002 (unaudited)

    

4

         

d) Notes to Condensed Financial Statements

    

5

    

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

    

7

    

Item 3.

  

Qualitative and Quantitative Disclosures About Market Risk

    

19

    

Item 4.

  

Controls and Procedures

    

19

PART II.

  

OTHER INFORMATION

      
    

Item 6.

  

Exhibits and Reports on Form 8-K

    

19

SIGNATURES

    

21

CERTIFICATIONS

    

22

EXHIBIT INDEX

    

25


Table of Contents

 

PART 1—FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

DENDREON CORPORATION

 

CONDENSED BALANCE SHEETS

(in thousands, except share and per share amounts)

 

    

March 31,

2003


    

December 31,

2002


 
    

(unaudited)

        

ASSETS

                 

Current assets:

                 

Cash and cash equivalents

  

$

13,321

 

  

$

11,263

 

Short-term investments

  

 

34,133

 

  

 

35,614

 

Restricted cash

  

 

—  

 

  

 

308

 

Accounts receivable

  

 

623

 

  

 

1,760

 

Other current assets

  

 

1,692

 

  

 

2,309

 

    


  


Total current assets

  

 

49,769

 

  

 

51,254

 

Property and equipment, net

  

 

3,428

 

  

 

3,578

 

Long-term investments

  

 

—  

 

  

 

8,102

 

Deposits and other assets

  

 

788

 

  

 

790

 

    


  


Total assets

  

$

53,985

 

  

$

63,724

 

    


  


LIABILITIES AND STOCKHOLDERS’ EQUITY

                 

Current liabilities:

                 

Accounts payable

  

$

402

 

  

$

1,041

 

Accrued liabilities

  

 

5,199

 

  

 

4,923

 

Accrued compensation

  

 

998

 

  

 

1,892

 

Deferred revenue

  

 

4,700

 

  

 

5,096

 

Current portion of capital lease obligations

  

 

1,172

 

  

 

1,198

 

    


  


Total current liabilities

  

 

12,471

 

  

 

14,150

 

Deferred revenue, less current portion

  

 

2,987

 

  

 

3,750

 

Capital lease obligations, less current portion

  

 

1,093

 

  

 

1,081

 

Stockholders’ equity:

                 

Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued or outstanding

  

 

—  

 

  

 

—  

 

Common stock, $0.001 par value; 80,000,000 shares authorized, 26,813,004 and 26,558,506 shares issued and outstanding at March 31, 2003 and December 31, 2002, respectively

  

 

27

 

  

 

27

 

Additional paid-in capital

  

 

160,684

 

  

 

160,314

 

Deferred stock-based compensation

  

 

(178

)

  

 

(253

)

Accumulated other comprehensive income

  

 

71

 

  

 

118

 

Accumulated deficit

  

 

(123,170

)

  

 

(115,463

)

    


  


Total stockholders’ equity

  

 

37,434

 

  

 

44,743

 

    


  


Total liabilities and stockholders’ equity

  

$

53,985

 

  

$

63,724

 

    


  


 

See accompanying notes

 

2


Table of Contents

 

DENDREON CORPORATION

 

CONDENSED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)

 

    

Three Months Ended

March 31,


 
    

2003


    

2002


 

Revenue

  

$

1,776

 

  

$

3,028

 

Operating expenses:

                 

Research and development

  

 

6,940

 

  

 

8,376

 

General and administrative

  

 

2,571

 

  

 

2,317

 

Marketing

  

 

86

 

  

 

261

 

    


  


Total operating expenses

  

 

9,597

 

  

 

10,954

 

    


  


Loss from operations

  

 

(7,821

)

  

 

(7,926

)

Interest income, net:

                 

Interest income

  

 

215

 

  

 

632

 

Interest expense

  

 

(101

)

  

 

(89

)

    


  


Interest income, net

  

 

114

 

  

 

543

 

    


  


Net loss

  

$

(7,707

)

  

$

(7,383

)

    


  


Basic and diluted net loss per share

  

$

(0.29

)

  

$

(0.30

)

    


  


Shares used in computation of basic and diluted net loss per share

  

 

26,729

 

  

 

24,983

 

    


  


 

See accompanying notes

 

3


Table of Contents

 

DENDREON CORPORATION

 

CONDENSED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

    

Three Months Ended

March 31,


 
    

2003


    

2002


 

OPERATING ACTIVITIES:

                 

Net loss

  

$

(7,707

)

  

$

(7,383

)

Adjustments to reconcile net loss to net cash used in operating activities:

                 

Depreciation expense

  

 

480

 

  

 

423

 

Non-cash stock-based compensation expense

  

 

75

 

  

 

200

 

Non-cash consulting expense

  

 

39

 

  

 

—  

 

Non-cash interest expense

  

 

3

 

  

 

3

 

Changes in current assets and liabilities

                 

Accounts receivable

  

 

1,137

 

  

 

149

 

Other current assets

  

 

689

 

  

 

582

 

Deposits and other assets

  

 

2

 

  

 

—  

 

Deferred revenue

  

 

(1,159

)

  

 

(1,403

)

Accounts payable

  

 

(639

)

  

 

29

 

Accrued liabilities and compensation

  

 

(618

)

  

 

(1,602

)

    


  


Net cash used in operating activities

  

 

(7,698

)

  

 

(9,002

)

    


  


INVESTING ACTIVITIES:

                 

Purchases of investments

  

 

(6,606

)

  

 

(31,054

)

Maturities of investments

  

 

16,142

 

  

 

51,754

 

Proceeds from asset disposals

  

 

500

 

  

 

—  

 

Purchases of property and equipment

  

 

(330

)

  

 

(555

)

Deferred acquisition costs

  

 

(306

)

  

 

—  

 

    


  


Net cash provided by investing activities

  

 

9,400

 

  

 

20,145

 

    


  


FINANCING ACTIVITIES:

                 

Payments on long-term debt

  

 

—  

 

  

 

(281

)

Payments on capital lease obligations

  

 

(266

)

  

 

(278

)

Proceeds from equipment financing arrangement

  

 

252

 

  

 

—  

 

Proceeds from employee stock purchase plan

  

 

285

 

  

 

324

 

Proceeds from exercise of stock options

  

 

85

 

  

 

32

 

    


  


Net cash provided by (used in) financing activities

  

 

356